Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 67 (5), 1672-1676
- https://doi.org/10.1111/j.1523-1755.2005.00261.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)Circulation, 2002
- HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathwayJournal of Clinical Investigation, 2001
- Endothelial-like cells derived from human CD14 positive monocytesDifferentiation, 2000
- In vitro differentiation of endothelial cells from AC133-positive progenitor cellsBlood, 2000
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences, 2000
- Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological NeovascularizationCirculation Research, 1999
- Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferonNature Medicine, 1999
- Evidence for Circulating Bone Marrow-Derived Endothelial CellsBlood, 1998
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997